addnok 0,4 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 0,4 mg / 1 tableta - buprenorfin
addnok 2 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 2 mg / 1 tableta - buprenorfin
addnok 0,4 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 0,4 mg / 1 tableta - buprenorfin
addnok 0,4 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 0,4 mg / 1 tableta - buprenorfin
addnok 2 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 2 mg / 1 tableta - buprenorfin
addnok 2 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 2 mg / 1 tableta - buprenorfin
addnok 8 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 8 mg / 1 tableta - buprenorfin
addnok 8 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 8 mg / 1 tableta - buprenorfin
addnok 8 mg podjezične tablete
activase pharmaceuticals ltd. - buprenorfin - podjezična tableta - buprenorfin 8 mg / 1 tableta - buprenorfin
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - cepiva - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.